CARBIDOPA

N/A

Manufactured by Bausch Health US, LLC

6,903 FDA adverse event reports analyzed

Last updated: 2026-04-15

About CARBIDOPA

CARBIDOPA is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Bausch Health US, LLC. The most commonly reported adverse reactions for CARBIDOPA include HALLUCINATION, DRUG INEFFECTIVE, FALL, DEATH, FATIGUE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CARBIDOPA.

Top Adverse Reactions

HALLUCINATION290 reports
DRUG INEFFECTIVE277 reports
FALL242 reports
DEATH237 reports
FATIGUE196 reports
DIZZINESS193 reports
NAUSEA190 reports
PARKINSON^S DISEASE166 reports
CONFUSIONAL STATE146 reports
TREMOR128 reports
GAIT DISTURBANCE123 reports
SOMNOLENCE119 reports
ASTHENIA118 reports
CONDITION AGGRAVATED117 reports
HALLUCINATION, VISUAL114 reports
PRODUCT DOSE OMISSION ISSUE112 reports
CONSTIPATION110 reports
INSOMNIA101 reports
URINARY TRACT INFECTION101 reports
VOMITING101 reports
DYSKINESIA97 reports
OFF LABEL USE92 reports
DYSPNOEA81 reports
PNEUMONIA80 reports
HEADACHE79 reports
PAIN79 reports
ANXIETY74 reports
DRUG INTERACTION74 reports
MEMORY IMPAIRMENT74 reports
MALAISE73 reports
DIARRHOEA72 reports
DEPRESSION71 reports
FEELING ABNORMAL71 reports
DEMENTIA65 reports
HYPOTENSION65 reports
DELUSION64 reports
COUGH61 reports
AGITATION58 reports
BALANCE DISORDER58 reports
WEIGHT DECREASED58 reports
PAIN IN EXTREMITY56 reports
DECREASED APPETITE54 reports
DYSPHAGIA52 reports
BLOOD PRESSURE INCREASED51 reports
BLOOD PRESSURE DECREASED49 reports
ARTHRALGIA47 reports
HIP FRACTURE47 reports
MUSCULAR WEAKNESS47 reports
RENAL FAILURE47 reports
SPEECH DISORDER47 reports
SYNCOPE47 reports
DEHYDRATION45 reports
HYPERTENSION44 reports
ABDOMINAL PAIN43 reports
PERIPHERAL SWELLING43 reports
BACK PAIN42 reports
MUSCULOSKELETAL STIFFNESS42 reports
ON AND OFF PHENOMENON42 reports
RASH42 reports
ABNORMAL BEHAVIOUR41 reports
MUSCLE SPASMS41 reports
LOSS OF CONSCIOUSNESS40 reports
ABDOMINAL DISCOMFORT39 reports
CHRONIC KIDNEY DISEASE39 reports
DEVICE ISSUE37 reports
MOBILITY DECREASED37 reports
PRURITUS37 reports
CEREBROVASCULAR ACCIDENT36 reports
COGNITIVE DISORDER36 reports
OEDEMA PERIPHERAL36 reports
SLEEP DISORDER36 reports
ABDOMINAL PAIN UPPER35 reports
ACUTE KIDNEY INJURY35 reports
ANAEMIA35 reports
HYPERHIDROSIS35 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION35 reports
TOXICITY TO VARIOUS AGENTS35 reports
DISORIENTATION34 reports
INCORRECT DOSE ADMINISTERED34 reports
PRODUCT USE IN UNAPPROVED INDICATION34 reports
GENERAL PHYSICAL HEALTH DETERIORATION33 reports
HYPERSOMNIA33 reports
PRODUCT DOSE OMISSION33 reports
WEIGHT INCREASED33 reports
ABDOMINAL DISTENSION32 reports
CONTUSION32 reports
HYPOAESTHESIA32 reports
MYOCARDIAL INFARCTION32 reports
PYREXIA32 reports
ADVERSE DRUG REACTION31 reports
PRODUCT USE ISSUE31 reports
DEPRESSED MOOD30 reports
DRY MOUTH30 reports
ILEUS30 reports
MUSCLE RIGIDITY30 reports
NASOPHARYNGITIS30 reports
ORTHOSTATIC HYPOTENSION30 reports
OVERDOSE30 reports
CHEST PAIN29 reports
GAIT INABILITY29 reports

Report Outcomes

Out of 2,978 classified reports for CARBIDOPA:

Serious 61.2%Non-Serious 38.8%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male1,504 (55.0%)
Female1,231 (45.0%)
Unknown2 (0.1%)

Reports by Age

Age 7598 reports
Age 7788 reports
Age 6884 reports
Age 7178 reports
Age 7375 reports
Age 8075 reports
Age 7272 reports
Age 7871 reports
Age 7070 reports
Age 8169 reports
Age 7467 reports
Age 7966 reports
Age 7662 reports
Age 8354 reports
Age 6751 reports
Age 8251 reports
Age 6950 reports
Age 6642 reports
Age 6439 reports
Age 8538 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CARBIDOPA?

This profile reflects 6,903 FDA FAERS reports that mention CARBIDOPA. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CARBIDOPA?

Frequently reported terms in FAERS include HALLUCINATION, DRUG INEFFECTIVE, FALL, DEATH, FATIGUE, DIZZINESS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CARBIDOPA?

Labeling and FAERS entries often list Bausch Health US, LLC in connection with CARBIDOPA. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.